- Kalmer is a mobile EMA/EMI intervention for 14-25-year-olds engaging in NSSI, integrating CBT and DBT strategies.
- Usability study (n=26, ages 16-25) produced high usability (SUS mean 81), good objective quality (3.88/5), perceived usefulness 3.66/5.
- Kalmer increased self-awareness, knowledge and help-seeking attitudes; needs enhanced content personalisation and engagement, supporting feasibility for future clinical trials.
Front Digit Health. 2026 Jun 3;8:1794576. doi: 10.3389/fdgth.2026.1794576. eCollection 2026.
ABSTRACT
INTRODUCTION: Non-suicidal self-injury (NSSI), defined as the deliberate infliction of harm to oneself without suicidal intent, poses a significant and growing mental health concern worldwide, particularly among adolescents and young adults. This behavior is associated with considerable emotional, social, and economic burdens, and is closely linked to heightened risks of future psychological challenges, including suicidal behavior. Digital interventions based on Ecological Momentary Assessment (EMA) and Ecological Momentary Intervention (EMI) offer promising solutions by overcoming access barriers of traditional therapies. This study introduces Kalmer, a mobile app designed to aid young individuals (ages 14-25) engaging in NSSI, integrating Cognitive Behavioral Therapy (CBT) and Dialectical Behavior Therapy (DBT) strategies.
METHODS: A usability study was conducted with 26 non-clinical participants aged 16-25, evaluating app’s functionality, satisfaction, and acceptability.
RESULTS: Results indicate high usability scores (SUS mean: 81) and positive perceptions regarding quality. Users assess the objective quality to be good (mean = 3.88/5), subjective quality to be improvable (mean = 2,99/5) and perceived the app as useful (mean = 3,66/5).
DISCUSSION: Kalmer demonstrated potential to increase self-awareness, knowledge, and help-seeking attitudes. Areas for improvement include enhanced content personalization and user engagement. These findings support the feasibility of Kalmer as a complementary tool in NSSI treatment and lay groundwork for future clinical trials in public health contexts.
PMID:42317640 | PMC:PMC13271978 | DOI:10.3389/fdgth.2026.1794576
Share Evidence Blueprint
Save to Google Notes

Search Google Scholar
⭐ My Revision List

